During the past decade, Illinois CancerCare-Eureka conducted 200 clinical trials. In the 10-year time frame, 200 clinical trials started and 161 clinical trials were completed, i.e. on average, 80.5% percent of trials that started reached the finish line to date. In the past 5 years, 95 clinical trials started and 87 clinical trials were completed. i.e. 91.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Illinois CancerCare-Eureka" #1 sponsor was "National Cancer Institute (NCI)" with 155 trials, followed by "Alliance for Clinical Trials in Oncology" with 77 trials sponsored, "SWOG Cancer Research Network" with 56 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 26 trials sponsored and "NRG Oncology" with 26 trials sponsored. Other sponsors include 21 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Illinois CancerCare-Eureka" #1 collaborator was "National Cancer Institute (NCI)" with 191 trials as a collaborator, "NRG Oncology" with 27 trials as a collaborator, "Canadian Cancer Trials Group" with 12 trials as a collaborator, "SWOG Cancer Research Network" with 7 trials as a collaborator and "Cancer and Leukemia Group B" with 6 trials as a collaborator. Other collaborators include 41 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Illinois CancerCare-Eureka" are "Breast Cancer" (18 trials), "Stage IV Lung Cancer AJCC v8" (11 trials), "Invasive Breast Carcinoma" (10 trials), "Lymphoma" (10 trials) and "Recurrent Breast Carcinoma" (10 trials). Many other conditions were trialed in "Illinois CancerCare-Eureka" in a lesser frequency.

Most popular intervention types in "Illinois CancerCare-Eureka" are "Drug" (279 trials), "Other" (212 trials), "Biological" (138 trials), "Procedure" (82 trials) and "Radiation" (51 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (94 trials), "Quality-of-Life Assessment" (81 trials), "Questionnaire Administration" (55 trials), "Computed Tomography" (42 trials) and "Biospecimen Collection" (40 trials). Other intervention names were less common.

The vast majority of trials in "Illinois CancerCare-Eureka" are 288 trials for "All" genders, 51 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Illinois CancerCare-Eureka". undefined are not yet recruiting, 88 are recruiting, 140 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 92 completed trials in Illinois CancerCare-Eureka, 9 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in Illinois CancerCare-Eureka, 20 "Phase 1" clinical trials were conducted, 178 "Phase 2" clinical trials and 164 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 8 trials that are defined as “Not Applicable".